New Opioid Policy Steering Committee
On September 29 of this year, the Food and Drug Administration (FDA) published a notice — Opioid Policy Steering Committee; Establishment of a Public Docket; Request for Comments — in the Federal Register, The Daily Journal of the United States Government.
The FDA is seeking comments from members of the public, including chronic pain patients and their families, healthcare professionals, academic institutions, and industry relative to the FDA’s new Opioid Policy Steering Committee (OPSC).
FDA Commissioner Scott Gottlieb, M.D. has expressed his commitment to confronting the opioid crisis and reducing the possibility of opioid addiction. He established the OPSC, and charged the committee with seeking input from the public.